Influence of Different Types of Antiandrogens on Luteinizing Hormone-Releasing Hormone Analogue-Induced Testosterone Surge in Patients with Metastatic Carcinoma of the Prostate
Author:
Affiliation:
1. From the Department of Urology, University of Bochum, Herne, Federal Republic of Germany
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Urology
Reference34 articles.
1. Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists;Tolis;Proc. Natl. Acad. Sci.,1982
2. Gonadotropin-releasing hormone analogues for prostate cancer: untoward side effects of high-dose regimens acquire a therapeutical dimension;Jacobi;Eur. Urol.,1982
3. Sustained suppression of testosterone production by the luteinising-hormone releasing-hormone agonist buserelin in patients with advanced prostate carcinoma. A new therapeutic approach?;Borgmann;Lancet,1982
4. Treatment with gonadotrophin releasing hormone analogue in advanced prostatic cancer;Waxman;Brit. Med. J.,1983
5. Advanced carcinoma of the prostate: treatment with a gonadotrophin releasing hormone agonist;Allen;Brit. Med. J.,1983
Cited by 49 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Hormone Treatment of Prostate Cancer:;Urologic Clinics of North America;2022-05
2. Evolution of Androgen Deprivation Therapy (ADT) and Its New Emerging Modalities in Prostate Cancer: An Update for Practicing Urologists, Clinicians and Medical Providers;Research and Reports in Urology;2022-03
3. A review of clinical evidence to assess differences in efficacy and safety of luteinizing hormone–releasing hormone (LHRH) agonist (goserelin) and LHRH antagonist (degarelix);Indian Journal of Cancer;2022
4. How I Treat Metastatic Hormone-Sensitive Prostate Cancer?;Indian Journal of Medical and Paediatric Oncology;2021-03
5. Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology;Journal of the National Comprehensive Cancer Network;2019-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3